Foresite Capital Management Ii 13F annual report

Foresite Capital Management Ii is an investment fund managing more than $39.6 billion ran by James Tananbaum. There is currently 1 company in Mr. Tananbaum’s portfolio. The largest and only investment include 10x Genomics worth $39.6 billion.

$39.6 billion Assets Under Management (AUM)

As of 4th August 2023, Foresite Capital Management Ii’s top holding is 708,528 shares of 10x Genomics currently worth over $39.6 billion and making up 100.0% of the portfolio value. Relative to the number of outstanding shares of 10x Genomics, Foresite Capital Management Ii owns more than approximately 0.1% of the company.

Currently, Foresite Capital Management Ii's portfolio is worth at least $39.6 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Foresite Capital Management Ii

The Foresite Capital Management Ii office and employees reside in Larkspur, California. According to the last 13-F report filed with the SEC, James Tananbaum serves as the Managing Member at Foresite Capital Management Ii.

One of the smallest hedge funds

The two most similar investment funds to Foresite Capital Management Ii are Caxton Corp and Richmond Brothers. They manage $39.5 billion and $39.4 billion respectively.

James Tananbaum investment strategy

Foresite Capital Management Ii’s portfolio is diversified across 1 sector. Currently, their heaviest sector is Health Care — making up 100.0% of the total portfolio value. The fund focuses on investments in the United States as 100.0% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up approximately 0.1% of the total holdings value. On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio. The average market cap of the portfolio companies is close to $4 billion.

The complete list of Foresite Capital Management Ii trades based on 13F SEC filings

These positions were updated on August 11th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security	Shares Owned	Value	Allocation
10x Genomics, Inc.	No change 708,528	$39,564,204,000	100.00%
No transactions found
Showing first 500 out of 1 holdings